Insights

Health and Life Sciences icon

Can the UK innovate its way beyond the frictions? The case of clinical trials regulations

Health and Life Sciences

Rachel Lygoe
|

At the start of this year, the UK Medicines and Healthcare products Regulatory Agency (MHRA) launched a consultation on its proposals for legislative changes to clinical trials. The consultation marks the latest in a series of efforts to reform the UK’s life sciences regulatory landscape post-Brexit and create a “world-class sovereign regulatory environment for clinical…

Read more